FVA
+0.0 · +0.00%
GBX · LSE

Fevara plc(FVA) Stock Analysis | Consumer Defensive

GBX --+0.00%
Reward56Moderate
Risk23Low
75%Data
Strong 22% profit margin
Profitless Growth
Market Cap:69.66M
ⓘ
Reward Rating
56
Moderate
Reward Assessment
75% data coverage
Bottom 50% of stocksView factors
ⓘ
Risk Rating
23
Low
Risk Assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on FVA to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Fevara plc?

Fevara plc engages in the agriculture business in the United Kingdom and internationally.

AI Brief Pro

The brief on Fevara plc

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Fevara plc?

Fevara plc engages in the agriculture business in the United Kingdom and internationally. The company develops, manufactures, and sells research-proven supplements, including feed licks, blocks, bagged minerals, and boluses for cattle, sheep, and horses under the following brands: Crystalyx, HorsLic, Horslyx, Scotmin Nutrition, Smartlic, Tracesure Advanced, Feed in a Drum, New Generation Supplements, Megastart, and Biosprint. The company is listed on the LSE in UK, operating in the Consumer Defensive sector, with a market capitalisation of 69.66M, and a P/E ratio of 22.4x.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Below-average volatility supports a steadier risk profile.
Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (56)

Similar stocks to compare

A short list of Packaged Foods names that are close enough in size to make side-by-side comparison useful.

All Consumer Defensive stocks →
Company Information
IndustryPackaged Foods
P/E Ratio22.4167
Beta0.35
Insider Activity
12M windowAwaiting coverage
LSE director-dealings coverage launching later this year. The data feed is in development.